Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2024 Filed May 17, 2024 20:33 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $86.23 | $0.00 |
DisclosureSEC source: 0001628280-24-024092 · wk-form4_1715977992.xml · derivative · entry 4 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,000 shares Expires 2027-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:33 UTC |
FELDMANN CYNTHIA LDirector
|
SaleOrdinary Shares | 2,000 | $237.65 | $475,300.00 |
DisclosureSEC source: 0001628280-24-024092 · wk-form4_1715977992.xml · nonDerivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 705 Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:33 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionOrdinary Shares | 2,000 | $86.23 | $172,460.00 |
DisclosureSEC source: 0001628280-24-024092 · wk-form4_1715977992.xml · nonDerivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 32,000 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 32,000 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 32,000 ordinary shares for $77.07 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 6,180 | $236.22 | $1,459,839.60 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,464 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $236.08 to $236.45 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F5 · balance_after: As of May 15, 2024, 11,455 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,293 on May 31, 2024; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026 and 564 on June 2, 2026. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 17,500 | $235.84 | $4,127,200.00 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,644 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $235.07 to $236.06 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 3,281 | $234.54 | $769,525.74 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,144 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $234.0450 to $234.9550 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 5,039 | $233.34 | $1,175,800.26 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,425 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $233.02 to $233.97 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2024 Filed May 17, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 32,000 | $77.07 | $2,466,240.00 |
DisclosureSEC source: 0001628280-24-024086 · wk-form4_1715977869.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC |
Sohi MohsenDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 2,037 | $0.00 Strike: $51.53 | $0.00 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,037 shares Expires 2024-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 2,037 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 2,037 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC |
Sohi MohsenDirector
|
SaleOrdinary Shares | 1,438 | $234.04 | $336,549.52 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · nonDerivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,361 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $233.47 to $234.3750 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC |
Sohi MohsenDirector
|
SaleOrdinary Shares | 599 | $232.96 | $139,543.04 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · nonDerivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,799 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $232.46 to $233.45 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:33 UTC |
Sohi MohsenDirector
|
Exercise / conversionOrdinary Shares | 2,037 | $51.53 | $104,966.61 |
DisclosureSEC source: 0001628280-24-023800 · wk-form4_1715891577.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2024 Filed May 16, 2024 20:31 UTC |
Burton Karen LVP & CAO
|
SaleOrdinary Shares | 3,000 | $235.95 | $707,850.00 |
DisclosureSEC source: 0001628280-24-023798 · wk-form4_1715891467.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,759 F1 · balance_after: As of May 14, 2024, 2,457 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 340 on May 31, 2024; 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 340 on June 2, 2025; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025; 340 on June 1, 2026 and 225 on June 2, 2026. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:39 UTC |
KOSECOFF JACQUELINE BDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 4,584 | $0.00 Strike: $51.53 | $0.00 |
DisclosureSEC source: 0001628280-24-023614 · wk-form4_1715805545.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 4,584 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,584 ordinary shares for $51.53 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:39 UTC |
KOSECOFF JACQUELINE BDirector
|
SaleOrdinary Shares | 4,584 | $231.53 | $1,061,333.52 |
DisclosureSEC source: 0001628280-24-023614 · wk-form4_1715805545.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $231.3719 to $231.74 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:39 UTC |
KOSECOFF JACQUELINE BDirector
|
Exercise / conversionOrdinary Shares | 4,584 | $51.53 | $236,213.52 |
DisclosureSEC source: 0001628280-24-023614 · wk-form4_1715805545.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:38 UTC |
Majors Cary LSVP and President, Healthcare
|
SaleOrdinary Shares | 2,024 | $232.13 | $469,831.12 |
DisclosureSEC source: 0001628280-24-023609 · wk-form4_1715805468.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,369 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $231.9703 to $232.2750 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of May 13, 2024, 9,860 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026 and 2,140 on June 2, 2026. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057609 · doc4.xml · derivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: All STERIS Restricted Stock Units are fully vested. F3 · derivative.exercise_date: All STERIS Restricted Stock Units are fully vested. F3 · derivative.expiration_date: All STERIS Restricted Stock Units are fully vested. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 98 | $199.27 | $19,528.46 |
DisclosureSEC source: 0001209191-23-057609 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,471 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of December 4, 2023, 2,912 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 426 on May 31, 2024, 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057609 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of December 4, 2023, 2,912 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 426 on May 31, 2024, 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| October 09, 2023 Filed Oct 11, 2023 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 605 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052635 · doc4.xml · derivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333 Underlying: Ordinary Shares · 605 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 333 on December 2, 2023. Read SEC document |
| October 09, 2023 Filed Oct 11, 2023 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 178 | $225.81 | $40,194.18 |
DisclosureSEC source: 0001209191-23-052635 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,236 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: As of October 9, 2023, 2,912 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 426 on May 31, 2024, 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| October 09, 2023 Filed Oct 11, 2023 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 605 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-052635 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of October 9, 2023, 2,912 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 426 on May 31, 2024, 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 16:35 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 85 | $215.50 | $18,317.50 |
DisclosureSEC source: 0001209191-23-051986 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,809 F1 · shares: 85 shares were withheld from the 289 restricted shares that vested on October 2, 2023. These 85 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Xilas on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 2,912 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 426 on May 31, 2024, 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 171 | $215.50 | $36,850.50 |
DisclosureSEC source: 0001209191-23-051984 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,551 F1 · shares: 171 shares were withheld from the 493 restricted shares that vested on October 2, 2023. These 171 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 493 ordinary shares were awarded to Ms. Madsen on October 1, 2020 and October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 4,270 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC |
Burton Karen LVP, Controller & CAO
|
Tax withholdingOrdinary Shares | 26 | $215.50 | $5,603.00 |
DisclosureSEC source: 0001209191-23-051985 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,759 F1 · shares: 26 shares were withheld from the 86 restricted shares that vested on October 2, 2023. These 26 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 86 ordinary shares were awarded to Ms. Burton on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 2,457 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 340 on May 31, 2024; 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 340 on June 2, 2025; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025; 340 on June 1, 2026 and 225 on June 2, 2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 61 | $215.50 | $13,145.50 |
DisclosureSEC source: 0001209191-23-051988 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,283 F1 · shares: 61 shares were withheld from the 202 restricted shares that vested on October 2, 2023. These 61 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 8,803 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on May 31, 2024; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 1,157 on June 2, 2025; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025; 1,157 on June 1, 2026 and 846 on June 2, 2026. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:35 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 130 | $215.50 | $28,015.00 |
DisclosureSEC source: 0001209191-23-051983 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,976 F1 · shares: 130 shares were withheld from the 289 restricted shares that vested on October 2, 2023. These 130 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Carestio on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. F2 · balance_after: As of October 2, 2023, 24,745 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,308 on May 31, 2024; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCareer Restricted Stock Units · Derivative | 364 | $225.50 | $82,082.00 |
DisclosureSEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,052 Underlying: Ordinary Shares · 364 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCareer Restricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,688 Underlying: Ordinary Shares · 525 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 261 | $76.72 Strike: $225.50 | $20,023.92 |
DisclosureSEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,805 Underlying: Ordinary Shares · 261 shares Expires 2033-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $20,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,544 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044829 · doc4.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544 Underlying: Ordinary Shares · 1,544 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 364 | $225.50 | $82,082.00 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,210 Underlying: Ordinary Shares · 364 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,846 Underlying: Ordinary Shares · 525 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 195 | $76.72 Strike: $225.50 | $14,960.40 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,740 Underlying: Ordinary Shares · 195 shares Expires 2033-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,545 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044828 · doc4.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,545 Underlying: Ordinary Shares · 1,545 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Shah Nirav RDirector
|
GrantCareer Restricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044826 · doc4.xml · derivative · entry 2 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,522 Underlying: Ordinary Shares · 525 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Shah Nirav RDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,544 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044826 · doc4.xml · derivative · entry 1 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544 Underlying: Ordinary Shares · 1,544 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Alegria Esther M.Director
|
GrantCareer Restricted Stock Units · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044827 · doc4.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,421 Underlying: Ordinary Shares · 1,050 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 279 | $225.50 | $62,914.50 |
DisclosureSEC source: 0001209191-23-044825 · doc4.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,273 Underlying: Ordinary Shares · 279 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $63,000 in fees. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044825 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,994 Underlying: Ordinary Shares · 831 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 2,443 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044825 · doc4.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,443 Underlying: Ordinary Shares · 2,443 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
GrantCareer Restricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044824 · doc4.xml · derivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,147 Underlying: Ordinary Shares · 525 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Options (right to buy) · Derivative | 1,544 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044824 · doc4.xml · derivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544 Underlying: Ordinary Shares · 1,544 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Martin Paul EdwardDirector
|
GrantCareer Restricted Stock Units · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044823 · doc4.xml · derivative · entry 1 Martin Paul Edward · CIK 0001700415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,581 Underlying: Ordinary Shares · 1,050 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 364 | $225.50 | $82,082.00 |
DisclosureSEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,850 Underlying: Ordinary Shares · 364 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,486 Underlying: Ordinary Shares · 525 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Breeden Richard CDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 326 | $76.72 Strike: $225.50 | $25,010.72 |
DisclosureSEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,870 Underlying: Ordinary Shares · 326 shares Expires 2033-08-03 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC |
Breeden Richard CDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,544 | $0.00 Strike: $225.50 | $0.00 |
DisclosureSEC source: 0001209191-23-044821 · doc4.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,544 Underlying: Ordinary Shares · 1,544 shares Expires 2033-08-03 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.